Rigel Pharmaceuticals Inc
RIGL· Nasdaq
Released Mar 6, 2012, before the open
10-K filed Mar 6, 2012, 66 days after period end · 0001047469-12-002146
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|
| EPS Diluted | -$0.36 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
ended Dec 31, 2011 · filed Mar 6, 2012 · 66 d after period end
5.0% from the close of Mar 5, 2012 to the close of Mar 6, 2012, the first after the release.